Regenarti AS is a Norwegian MedTech startup dedicated to developing innovative medical devices within orthopaedics. By leveraging an advanced peptide platform within hydrogel technology, Regenarti aims to treat and prevent osteoarthritis, addressing the critical need for enhanced solutions among patients and healthcare professionals.
As part of her industrial PhD, Angela has participated in the School of Health Innovation (SHI), which has significantly contributed to her entrepreneurial journey. SHI aims to pair healthcare and life sciences researchers with businesses, teaching them practical innovation and entrepreneurship skills. Focusing on promoting an innovative mindset among students, researchers, clinicians, and employees, SHI equips healthcare researchers with the tools and knowledge to innovate services, create new companies from their research ideas, or bring their talents into existing companies.
Originally established at the Faculty of Medicine at the University of Oslo (UiO), SHI became part of the services provided by the in-house innovation unit, the UiO Growth House, in June 2022. This collaboration between the Faculty of Medicine and the Faculty of Mathematics and Natural Sciences at UiO emphasises case-based and project-based learning, allowing participants like Angela to develop ideas directly from their research environment.
The Pitch Night, hosted by Start Norway in collaboration with The Conduit Oslo, showcased seven promising student-driven startups. Angela's compelling and inspiring pitch for Regenarti stood out, earning her the top prize amidst strong competition. This achievement highlights the importance of translational research and the entrepreneurial spirit fostered within our department.
We extend our heartfelt gratitude to Innovation Norway for believing in Angela's vision and providing her with a STUD-ENT student entrepreneurship grant with Øystein Øvrebø. This grant, under the initiative aims to strengthen the work with student innovation and entrepreneurship culture at universities and colleges across the country. Such support is instrumental in bridging the gap between academic research and real-world medical applications.
Way to go, Angela! Your success brings pride to our department and inspires fellow students and researchers to translate biomaterials. We celebrate your dedication to advancing biomaterials in medical science and your contribution to improving patient care.